Name
bri4a_tr
Label
Inhibit raw score
Type
numeric
Visit Number vs Inhibit raw score
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Baseline | 318 | 15.4 | ± 5.8 | 13.0 | 10.0 | 30.0 | 146 | 464 |
| Follow-up | 280 | 15.3 | ± 6.0 | 13.0 | 10.0 | 30.0 | 173 | 453 |
Treatment Arm vs Inhibit raw score
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 318 | 15.4 | ± 5.8 | 13.0 | 10.0 | 30.0 | 135 | 453 |
| Early adenotonsillectomy (EAT) | 161 | 15.6 | ± 6.0 | 13.0 | 10.0 | 30.0 | 65 | 226 |
| Watchful waiting with supportive care (WWSC) | 157 | 15.2 | ± 5.6 | 14.0 | 10.0 | 30.0 | 70 | 227 |
Treatment Arm vs Inhibit raw score
Follow-up
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 280 | 15.3 | ± 6.0 | 13.0 | 10.0 | 30.0 | 173 | 453 |
| Early adenotonsillectomy (EAT) | 136 | 14.6 | ± 5.3 | 12.0 | 10.0 | 30.0 | 90 | 226 |
| Watchful waiting with supportive care (WWSC) | 144 | 16.0 | ± 6.6 | 14.0 | 10.0 | 30.0 | 83 | 227 |
Age vs Inhibit raw score
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 318 | 15.4 | ± 5.8 | 13.0 | 10.0 | 30.0 | 135 | 453 |
| 5 - 7 years old | 232 | 15.3 | ± 5.5 | 14.0 | 10.0 | 30.0 | 97 | 329 |
| 8 - 10 years old | 86 | 15.5 | ± 6.5 | 12.0 | 10.0 | 30.0 | 38 | 124 |
Age vs Inhibit raw score
Follow-up
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 278 | 15.3 | ± 6.0 | 13.0 | 10.0 | 30.0 | 121 | 399 |
| 5 - 7 years old | 191 | 15.5 | ± 6.0 | 13.0 | 10.0 | 30.0 | 71 | 262 |
| 8 - 10 years old | 87 | 15.0 | ± 6.1 | 12.0 | 10.0 | 30.0 | 50 | 137 |
Gender vs Inhibit raw score
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 318 | 15.4 | ± 5.8 | 13.0 | 10.0 | 30.0 | 135 | 453 |
| Female | 160 | 13.9 | ± 4.9 | 12.0 | 10.0 | 29.0 | 74 | 234 |
| Male | 158 | 16.9 | ± 6.2 | 16.0 | 10.0 | 30.0 | 61 | 219 |
Gender vs Inhibit raw score
Follow-up
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 280 | 15.3 | ± 6.0 | 13.0 | 10.0 | 30.0 | 173 | 453 |
| Female | 149 | 14.3 | ± 5.6 | 12.0 | 10.0 | 30.0 | 85 | 234 |
| Male | 131 | 16.5 | ± 6.3 | 15.0 | 10.0 | 30.0 | 88 | 219 |
Race vs Inhibit raw score
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 318 | 15.4 | ± 5.8 | 13.0 | 10.0 | 30.0 | 135 | 453 |
| White | 119 | 14.9 | ± 6.0 | 13.0 | 10.0 | 30.0 | 37 | 156 |
| Black | 169 | 16.0 | ± 5.8 | 15.0 | 10.0 | 30.0 | 80 | 249 |
| Other | 30 | 14.1 | ± 4.8 | 13.0 | 10.0 | 29.0 | 18 | 48 |
Race vs Inhibit raw score
Follow-up
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 280 | 15.3 | ± 6.0 | 13.0 | 10.0 | 30.0 | 173 | 453 |
| White | 111 | 14.2 | ± 5.5 | 12.0 | 10.0 | 30.0 | 45 | 156 |
| Black | 141 | 16.3 | ± 6.3 | 15.0 | 10.0 | 30.0 | 108 | 249 |
| Other | 28 | 14.7 | ± 5.9 | 12.5 | 10.0 | 28.0 | 20 | 48 |